Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of filgotinib in adults with Crohn's disease
MOH_2017-07-13_000453Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of filgotinib in Crohn's disease (3 arms), sponsored by Gilead Sciences. Started Apr 2017; status: completed.
02
Drugs
filgotinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on MOH_2017-07-13_000453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-07-13_000453.